Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
12,13 USD | -0,33% | -4,71% | -33,02% |
Attività
Numero di dipendenti: 158
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapies
100,0
%
| 10 | 100,0 % | 2 | 100,0 % | -83,69% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 2 | 100,0 % | -83,69% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Bernard Coulie
CEO | Chief Executive Officer | 58 | 01/02/16 |
- | - | ||
Keith Cummings
DFI | Director of Finance/CFO | 47 | 01/12/18 |
Chief Tech/Sci/R&D Officer | - | 04/01/21 | |
Eric Lefebvre
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/05/18 |
Scott Turner
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/07/21 |
Investor Relations Contact | - | 01/11/20 | |
Minnie Kuo
PRN | Corporate Officer/Principal | - | 14/09/23 |
Corporate Officer/Principal | - | - | |
Rik Derynck
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 12/01/21 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 01/07/16 |
Gayle Crowell
BRD | Director/Board Member | 73 | 08/01/20 |
Ho Young Huh
CHM | Chairman | 54 | 01/12/17 |
Bernard Coulie
CEO | Chief Executive Officer | 58 | 01/02/16 |
Thomas McCourt
BRD | Director/Board Member | 66 | 06/03/23 |
Darren Cline
BRD | Director/Board Member | 59 | 06/03/23 |
John Curnutte
BRD | Director/Board Member | 72 | 01/08/17 |
Smital Shah
BRD | Director/Board Member | 48 | 14/03/19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 14/09/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 60 325 832 | 56 458 990 ( 93,59 %) | 0 | 93,59 % |
Coordinate società
Pliant Therapeutics, Inc.
260 Littlefield Avenue
94080, South San Francisco
+650 481 6770
http://www.pliantrx.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-33,02% | 732 Mln | |
+40,73% | 739 Mrd | |
+32,83% | 598 Mrd | |
-6,30% | 353 Mrd | |
+15,15% | 318 Mrd | |
+4,05% | 285 Mrd | |
+15,00% | 240 Mrd | |
+9,78% | 210 Mrd | |
-5,52% | 206 Mrd | |
+6,17% | 164 Mrd |
- Borsa valori
- Azioni
- Azione PLRX
- Società Pliant Therapeutics, Inc.